1. Home
  2. Labeler Index
  3. Bryant Ranch Prepack
  4. 71335-9688
  5. Product Images: Vardenafil Hydrochloride

Product Images Vardenafil Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Vardenafil Hydrochloride NDC 71335-9688 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Structural formula for vardenafil hydrochloride - image 1

Structural formula for vardenafil hydrochloride - image 1

Figure 1: Placebo-subtracted point estimates (with 90% CI) of mean maximal blood pressure and heart rate effects of pre-dosing with vardenafil 20 mg at 24, 8, 4, and 1 hour before 0.4 mg NTG sublingually - image 2

Figure 1: Placebo-subtracted point estimates (with 90% CI) of mean maximal blood pressure and heart rate effects of pre-dosing with vardenafil 20 mg at 24, 8, 4, and 1 hour before 0.4 mg NTG sublingually - image 2

Figure 2: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 5 mg or placebo with stable dose tamsulosin 0.4 mg in normotensive BPH patients (Study 1) - image 3

Figure 2: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 5 mg or placebo with stable dose tamsulosin 0.4 mg in normotensive BPH patients (Study 1) - image 3

Figure 3: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 5 mg or placebo with stable dose terazosin (5 or 10mg) in normotensive BPH patients (Study 1) - image 4

Figure 3: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 5 mg or placebo with stable dose terazosin (5 or 10mg) in normotensive BPH patients (Study 1) - image 4

This appears to be a data table showing the mean change in blood pressure (measured in mmHg) over a certain amount of time (measured in hours). However, without additional context, it is difficult to determine the specific purpose or significance of this data.*

Figure 4: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous administration of vardenafil 10 mg (Stage 1), vardenafil 20 mg (Stage 2), or placebo with stable dose tamsulosin 0.4 mg in normotensive BPH patients (Study 2) - image 5

Figure 4: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous administration of vardenafil 10 mg (Stage 1), vardenafil 20 mg (Stage 2), or placebo with stable dose tamsulosin 0.4 mg in normotensive BPH patients (Study 2) - image 5

Figure 5: Mean change from base line in standing systolic blood pressure (mmHg) over 6 hour interval following 4 hr separation administration of vardenafil 5 mg (stage 1), vardenafil 10 mg (stage 2) or placbo with stable dose alfuzosin 10 mg i BPH patients (Study 3) - image 6

Figure 5: Mean change from base line in standing systolic blood pressure (mmHg) over 6 hour interval following 4 hr separation administration of vardenafil 5 mg (stage 1), vardenafil 10 mg (stage 2) or placbo with stable dose alfuzosin 10 mg i BPH patients (Study 3) - image 6

This text shows a chart or a graph representing the Mean Change (in millimeters of mercury or mmHg) of two groups: Placebo (Stage 1 and Stage 2) and Varder. The graph has two points plotted and connected by a line for each group, with one point on the axis labeled "-o-" and the other labeled "-e-". The numerical value 10 is also present.*

Figure 5: Man change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 10 mg, vardenafil 20 mg or placebo with terazosin (10 mg) in healthy volunteers - image 7

Figure 5: Man change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 10 mg, vardenafil 20 mg or placebo with terazosin (10 mg) in healthy volunteers - image 7

Figure 6: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 10 mg, vardenafil 20 mg or placebo with tamsulosin (0.4 mg) in healthy volunteers - image 8

Figure 6: Mean change from baseline in standing systolic blood pressure (mmHg) over 6 hour interval following simultaneous or 6 hr separation administration of vardenafil 10 mg, vardenafil 20 mg or placebo with tamsulosin (0.4 mg) in healthy volunteers - image 8

Figure 7: Plasma Vardenafil Concentration (Mean plus or minus SD) Curve for a Single 20 mg vardenafil hydrochloride dose - image 9

Figure 7: Plasma Vardenafil Concentration (Mean plus or minus SD) Curve for a Single 20 mg vardenafil hydrochloride dose - image 9

Label - lbl713359688

Label - lbl713359688

This text describes a drug called Vardenafil Hydrochloride. Each tablet contains 20 mg of Vardenafil HCI. It should be kept away from children and stored at 20° to 25° C (68° to 77° F), with permissible excursions from 15° to 30° C (59° to 86° F). The drug should be dispensed in a tight container using a child-resistant closure. The pharmaceutical company involved is Bryant Ranch Prepack, Inc. The drug is available in 30-tablet packaging with the NDC code 71335-9688-1. The text also specifies the drug is for prescription-only use.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.